The United States International Development Finance Corporation (DFC) is a state-run development finance institution, which invests in development projects primarily in lower- and middle-income countries.
Leading a high-powered delegation, DFC Chief Operating Officer (COO) David Marchick would travel to India from October 24 to 26.
In Hyderabad, the delegation will visit the offices of the Indian vaccine manufacturer Biological E and participate in a signing ceremony to open a new facility with substantial capacity for vaccine manufacturing, an official release said.
“This work is in support of the historic commitment set out by President (Joe) Biden and his counterparts in the ‘Quad’ – Australia, India, Japan and the United States,” the DFC said in a statement.
Marchick would travel to India after his visit to South Africa beginning October 18. The travel to South Africa and India is to advance DFC investments helping boost global health and expand Covid-19 vaccine production capacity throughout the developing world.
DFC Vice President of Development Credit Jim Polan and other DFC senior staff will accompany the COO.
During the South Africa tour, the DFC delegation will visit Africa Data Centres, a DFC client that is developing and expanding critical technology infrastructure throughout Africa. The delegation will tour the sterile facilities of Aspen Pharmacare, Africa’s largest pharmaceutical manufacturer, in Gqeberha (formally known as Port Elizabeth), as well as meet with other pharmaceutical manufacturers critical to the Covid-19 response, a media release said.
“Since day one of the Biden administration, President Biden has stated that the only way to defeat Covid-19 is to end the pandemic both at home and abroad by vaccinating Americans at home and non-Americans abroad,” the DFC said.
The US has committed to donate 1.1 billion doses of Covid vaccines worldwide and has already shipped nearly 200 million doses to developing countries – more doses than the rest of the world combined, it said.